Loading...
$ 1,000
AOD-9604 (Advanced Obesity Drug-9604) is a modified form of the human growth hormone fragment 176-191. It consists of the C-terminal section of the HGH molecule, which researchers believe is responsible for the fat-burning effects of growth hormone, without influencing blood sugar or growth-promoting properties. It has been studied as a potential anti-obesity agent.
AOD-9604 primarily stimulates lipolysis (the breakdown of fat) and inhibits lipogenesis (the formation of fat) in laboratory models. This effect is thought to be mediated by its mimicry of the natural metabolic actions of growth hormone, particularly through binding to adipose (fat) tissue.
– Research published in Obesity Research & Clinical Practice explored AOD-9604’s effects on fat metabolism and found promising results in animal models.
– Clinical trials in Australia and the U.S. evaluated its impact on weight loss, though it was not FDA-approved for therapeutic use.
AOD-9604 is an intriguing peptide for laboratories studying metabolic disorders, obesity, and fat metabolism. Its potential lipolytic benefits without the systemic effects of HGH make it a focused tool for understanding adipose regulation. All uses must remain within research contexts, and it is not intended for human consumption or therapeutic applications.




(936) 931 8152
Monday – Friday 9AM – 4PM CST
Shipping Days
Mailing Address
Sign up to stay informed about our latest product releases, exclusive discounts, and in-depth product insights—delivered straight to your inbox